Healthcare -
Biotechnology - NASDAQ - US
$ 0.3798
-2.2 %
$ 10.7 M
Market Cap
-0.22
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
NextCure, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 59.7 M |
| Operating Income | -59.7 M |
| Other Expenses | -4.09 M |
| Net Income | -55.7 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 22.4 | 6.3 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 0 | 3.7 | 4.5 | 4.3 | 46.6 K | 34.2 K | 1.7 | 0.6 |
| Gross Profit | 0 | (3.7) | (4.5) | (4.3) | 22.3 | 6.3 | (1.7) | (0.6) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 59.7 | 67.6 | 75.9 | 70.8 | 63.6 | 43.8 | 23.2 | 15.5 |
| Selling, General and Administrative Expenses | 15.7 | 19.7 | 21.7 | 20.6 | 17.0 | 9.6 | 3.4 | 2.6 |
| Research and Development Expenses | 41.5 | 47.9 | 54.2 | 50.2 | 46.6 | 34.2 | 19.8 | 13.0 |
| Operating Income | (59.7) | (67.6) | (75.9) | (70.8) | (41.2) | (37.5) | (23.2) | (15.5) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 0 | 0 | 77 K | 0.2 | 0.2 | 0 | 0 |
| Total Other Income | 4.1 | 4.9 | 1.2 | 1.4 | 4.6 | 3.7 | 0.4 | 80 K |
| Pre-Tax Income | (55.7) | (62.7) | (74.7) | (69.4) | (36.6) | (33.7) | (22.8) | (15.5) |
| NET INCOME | ||||||||
| Tax Provision | 0 | 0 | (5.3) | 7.0 | (3.4) | 2.5 | 0.4 | 0 |
| Net Income | (55.7) | (62.7) | (69.4) | (69.4) | (33.2) | (33.7) | (22.8) | (15.5) |
| EPS | 1.99 | 2.25 | 2.5 | 2.51 | 1.21 | 2.15 | 2.27 | 1.54 |